Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Experience With the Priority Review Voucher Program for Drug Development

Experience With the Priority Review Voucher Program for Drug Development This Viewpoint assesses the US Food and Drug Administration’s priority review voucher program to encourage development of drugs to treat neglected tropical diseases or rare pediatric disease and recommends improvements to the program. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Experience With the Priority Review Voucher Program for Drug Development

JAMA , Volume 314 (16) – Oct 27, 2015

Loading next page...
 
/lp/american-medical-association/experience-with-the-priority-review-voucher-program-for-drug-A1BhsgZdPy

References (6)

Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2015.11845
pmid
26414802
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint assesses the US Food and Drug Administration’s priority review voucher program to encourage development of drugs to treat neglected tropical diseases or rare pediatric disease and recommends improvements to the program.

Journal

JAMAAmerican Medical Association

Published: Oct 27, 2015

There are no references for this article.